Quaternary ammonium compounds (QACs)
serve as mainstays in the
formulation of disinfectants and antiseptics. However, an over-reliance
and misuse of our limited QAC arsenal has driven the development and
spread of resistance to these compounds, as well as co-resistance
to common antibiotics. Extensive use of these compounds throughout
the COVID-19 pandemic thus raises concern for the accelerated proliferation
of antimicrobial resistance and demands for next-generation antimicrobials
with divergent architectures that may evade resistance. To this end,
we endeavored to expand beyond canonical ammonium scaffolds and examine
quaternary phosphonium compounds (QPCs). Accordingly, a synthetic
and biological investigation into a library of novel QPCs unveiled
biscationic QPCs to be effective antimicrobial scaffolds with improved
broad-spectrum activities compared to commercial QACs. Notably, a
subset of these compounds was found to be less effective against a
known QAC-resistant strain of MRSA. Bioinformatic analysis revealed
the unique presence of a family of small multiresistant transporter
proteins, hypothesized to enable efflux-mediated resistance to QACs
and QPCs. Further investigation of this resistance mechanism through
efflux-pump inhibition and membrane depolarization assays illustrated
the superior ability of P6P-10,10 to perturb the cell membrane and
exert the observed broad-spectrum potency compared to its commercial
counterparts. Collectively, this work highlights the promise of biscationic
phosphonium compounds as next-generation disinfectant molecules with
potent bioactivities, thereby laying the foundation for future studies
into the synthesis and biological investigation of this nascent antimicrobial
class.